[Modulation of the course of experimental tuberculosis in mice by in vivo administration of monoclonal antibodies to interleukin-2, gamma-interferon and interleukin-4].
The impact of the in vivo administration of monoclonal antibodies against cytokines on the development of a pathological process in mice infected with Mycobacterium tuberculosis H37Rv-infected mice. The susceptibility to fatal experimental tuberculosis, the level of DTH to mycobacterial antigens, the production of specific antimycobacterial IgG and IgM, T-cell proliferative responses to M. tuberculosis H37Rv antigens. Anti-gamma-interferon and anti-IL-2 treatment was found to provide virtually no effects on the course of experimental tuberculosis, the intravenous administration of anti-IL-4-monoclonal antibodies on days 2, 4, and 6 after inoculation with a lethal dose of M. tuberculosis significantly increases the median survival time (MST). This increase in MST is accompanied by a more prominent DTH response and lymphocytic proliferative reaction on the one hand, and by lower concentrations of specific IgG on the other. The therapeutical prospects of anti-IL-4 treatment in tuberculosis are discussed.